Patent law reforms and their implications for generics and innovators
Patent law reforms reshape the landscape for generics and innovators.
Category: Pharmaceuticals & Healthcare Products
Pharmaceuticals & Healthcare Products
The role of generics versus branded generics in the Indian healthcare system
Generics offer affordability, but branded generics build trust.
Ethical sourcing and supply chain transparency in pharma ingredients
Ensuring transparency in pharma sourcing builds trust and safety.
AI and machine learning applications in Indian drug discovery
AI is transforming drug discovery in India, boosting innovation.
Telemedicine and pharmaceutical delivery regulation post COVID
Post-COVID, telemedicine regulations are rapidly evolving.
Counterfeit and substandard drugs and policy efforts to address them
Combatting counterfeit drugs requires urgent global policy reform.
How India is preparing for future pandemics with vaccine capacity
India boosts vaccine production to combat future pandemics.
Pharma responses to inflation, input cost pressures and currency volatility
Pharma adapts strategies to tackle rising costs and volatility.
Strategies for managing excipient and packaging cost increases
Navigate rising excipient and packaging costs with smart strategies.
Export destination diversification and reducing reliance on few major markets
Exploring new markets can boost export stability and growth.